Advertisement
Loading...

Kelyniam Global, Inc.

KLYGPNK
Healthcare
Medical - Devices
$0.17
$-0.01(-5.56%)
U.S. Market opens in 10h 6m

Kelyniam Global, Inc. Fundamental Analysis

Kelyniam Global, Inc. (KLYG) shows weak financial fundamentals with a PE ratio of -61.44, profit margin of -4.54%, and ROE of -18.60%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-2.55

Areas of Concern

ROE-18.60%
Operating Margin-3.53%
Cash Position1.23%
Current Ratio0.79
We analyze KLYG's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -5.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-5.4/100

We analyze KLYG's fundamental strength across five key dimensions:

Efficiency Score

Weak

KLYG struggles to generate sufficient returns from assets.

ROA > 10%
-7.91%

Valuation Score

Excellent

KLYG trades at attractive valuation levels.

PE < 25
-61.44
PEG Ratio < 2
-2.55

Growth Score

Weak

KLYG faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

KLYG shows balanced financial health with some risks.

Debt/Equity < 1
0.63
Current Ratio > 1
0.79

Profitability Score

Weak

KLYG struggles to sustain strong margins.

ROE > 15%
-1859.91%
Net Margin ≥ 15%
-4.54%
Positive Free Cash Flow
No

Key Financial Metrics

Is KLYG Expensive or Cheap?

P/E Ratio

KLYG trades at -61.44 times earnings. This suggests potential undervaluation.

-61.44

PEG Ratio

When adjusting for growth, KLYG's PEG of -2.55 indicates potential undervaluation.

-2.55

Price to Book

The market values Kelyniam Global, Inc. at 10.47 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

10.47

EV/EBITDA

Enterprise value stands at -20.57 times EBITDA. This is generally considered low.

-20.57

How Well Does KLYG Make Money?

Net Profit Margin

For every $100 in sales, Kelyniam Global, Inc. keeps $-4.54 as profit after all expenses.

-4.54%

Operating Margin

Core operations generate -3.53 in profit for every $100 in revenue, before interest and taxes.

-3.53%

ROE

Management delivers $-18.60 in profit for every $100 of shareholder equity.

-18.60%

ROA

Kelyniam Global, Inc. generates $-7.91 in profit for every $100 in assets, demonstrating efficient asset deployment.

-7.91%

Following the Money - Real Cash Generation

Operating Cash Flow

Kelyniam Global, Inc. generates limited operating cash flow of $-48.78K, signaling weaker underlying cash strength.

$-48.78K

Free Cash Flow

Kelyniam Global, Inc. generates weak or negative free cash flow of $-48.78K, restricting financial flexibility.

$-48.78K

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

KLYG converts -9.05% of its market value into free cash.

-9.05%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-61.44

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.55

vs 25 benchmark

P/B Ratio

Price to book value ratio

10.47

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.70

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.63

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.79

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.19

vs 25 benchmark

ROA

Return on assets percentage

-0.08

vs 25 benchmark

ROCE

Return on capital employed

-0.10

vs 25 benchmark

How KLYG Stacks Against Its Sector Peers

MetricKLYG ValueSector AveragePerformance
P/E Ratio-61.4429.24 Better (Cheaper)
ROE-18.60%713.00% Weak
Net Margin-4.54%-42604.00% (disorted) Weak
Debt/Equity0.630.46 Weak (High Leverage)
Current Ratio0.794.36 Weak Liquidity
ROA-7.91%-16668.00% (disorted) Weak

KLYG outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Kelyniam Global, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ